PMC:7199903 / 0-249
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 72-79 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T2 | 210-217 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 37-45 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 55-63 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T3 | 116-163 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 116-149 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 165-173 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T6 | 233-242 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 177-187 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | is focused |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 72-79 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T2 | 210-217 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-4 | http://purl.obolibrary.org/obo/BFO_0000029 | denotes | Site |
T2 | 233-242 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infection |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T14 | 112-115 | IN | denotes | for |
T15 | 116-122 | JJ | denotes | severe |
T16 | 123-128 | JJ | denotes | acute |
T17 | 129-140 | JJ | denotes | respiratory |
T18 | 141-149 | NN | denotes | syndrome |
T19 | 150-161 | NN | denotes | coronavirus |
T20 | 162-163 | CD | denotes | 2 |
T21 | 164-165 | -LRB- | denotes | ( |
T0 | 0-13 | JJ | denotes | Site-specific |
T1 | 14-20 | NN | denotes | glycan |
T2 | 21-29 | NN | denotes | analysis |
T3 | 30-32 | IN | denotes | of |
T4 | 33-36 | DT | denotes | the |
T5 | 37-47 | NN | denotes | SARS-CoV-2 |
T6 | 48-53 | NN | denotes | spike |
T7 | 55-65 | NN | denotes | SARS-CoV-2 |
T8 | 66-71 | NN | denotes | spike |
T9 | 72-79 | NN | denotes | protein |
T10 | 79-80 | -COMMA- | denotes | , |
T11 | 81-91 | VBD | denotes | elaborated |
T12 | 92-99 | NN | denotes | Vaccine |
T13 | 100-111 | NN | denotes | development |
T22 | 165-175 | NN | denotes | SARS-CoV-2 |
T23 | 175-176 | -RRB- | denotes | ) |
T24 | 177-179 | VBZ | denotes | is |
T25 | 180-187 | VBN | denotes | focused |
T26 | 188-190 | IN | denotes | on |
T27 | 191-194 | DT | denotes | the |
T28 | 195-203 | JJ | denotes | trimeric |
T29 | 204-209 | NN | denotes | spike |
T30 | 210-217 | NN | denotes | protein |
T31 | 218-222 | WDT | denotes | that |
T32 | 223-232 | VBZ | denotes | initiates |
T33 | 233-242 | NN | denotes | infection |
T34 | 244-248 | DT | denotes | Each |
R0 | T2 | T0 | arg1Of | analysis,Site-specific |
R1 | T2 | T1 | arg1Of | analysis,glycan |
R2 | T2 | T3 | arg1Of | analysis,of |
R3 | T6 | T3 | arg2Of | spike,of |
R4 | T6 | T4 | arg1Of | spike,the |
R5 | T6 | T5 | arg1Of | spike,SARS-CoV-2 |
R6 | T9 | T7 | arg1Of | protein,SARS-CoV-2 |
R7 | T9 | T8 | arg1Of | protein,spike |
R21 | T13 | T24 | arg1Of | development,is |
R22 | T25 | T24 | arg2Of | focused,is |
R23 | T13 | T25 | arg2Of | development,focused |
R24 | T25 | T26 | arg1Of | focused,on |
R25 | T30 | T26 | arg2Of | protein,on |
R26 | T30 | T27 | arg1Of | protein,the |
R27 | T30 | T28 | arg1Of | protein,trimeric |
R28 | T30 | T29 | arg1Of | protein,spike |
R29 | T30 | T31 | arg1Of | protein,that |
R8 | T11 | T10 | arg1Of | elaborated,"," |
R9 | T9 | T11 | arg1Of | protein,elaborated |
R10 | T13 | T12 | arg1Of | development,Vaccine |
R11 | T13 | T14 | arg1Of | development,for |
R12 | T19 | T14 | arg2Of | coronavirus,for |
R13 | T19 | T15 | arg1Of | coronavirus,severe |
R14 | T19 | T16 | arg1Of | coronavirus,acute |
R15 | T19 | T17 | arg1Of | coronavirus,respiratory |
R16 | T19 | T18 | arg1Of | coronavirus,syndrome |
R17 | T19 | T20 | arg1Of | coronavirus,2 |
R18 | T19 | T21 | arg1Of | coronavirus,( |
R19 | T22 | T21 | arg2Of | SARS-CoV-2,( |
R20 | T23 | T21 | arg3Of | ),( |
R30 | T30 | T32 | arg1Of | protein,initiates |
R31 | T33 | T32 | arg2Of | infection,initiates |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 72-79 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T2 | 210-217 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 72-79 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T2 | 210-217 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T1 | 37-47 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
T2 | 55-65 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
T3 | 116-163 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | NCBItxid:2697049 |
T4 | 165-175 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-53 | Sentence | denotes | Site-specific glycan analysis of the SARS-CoV-2 spike |
T2 | 55-91 | Sentence | denotes | SARS-CoV-2 spike protein, elaborated |
T3 | 92-243 | Sentence | denotes | Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection. |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 37-47 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 55-65 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T3 | 116-163 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 165-175 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 233-242 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
17 | 204-209 | Gene | denotes | spike | Gene:43740568 |
19 | 116-163 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
2 | 37-47 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
20 | 165-175 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
25 | 233-242 | Disease | denotes | infection | MESH:D007239 |
6 | 66-71 | Gene | denotes | spike | Gene:43740568 |
7 | 55-65 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
T2 | 14-20 | Chemical | denotes | glycan | MESH:D011134 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T1 | 66-79 | Protein | denotes | spike protein | https://www.uniprot.org/uniprot/P31340 |
T2 | 204-217 | Protein | denotes | spike protein | https://www.uniprot.org/uniprot/P31340 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-53 | Sentence | denotes | Site-specific glycan analysis of the SARS-CoV-2 spike |
T2 | 55-91 | Sentence | denotes | SARS-CoV-2 spike protein, elaborated |
T3 | 92-243 | Sentence | denotes | Vaccine development for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the trimeric spike protein that initiates infection. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2 | 37-47 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
3 | 14-20 | Chemical | denotes | glycan | MESH:D011134 |
6 | 66-71 | Gene | denotes | spike | Gene:43740568 |
7 | 55-65 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
17 | 204-209 | Gene | denotes | spike | Gene:43740568 |
19 | 116-163 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
20 | 165-175 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
25 | 233-242 | Disease | denotes | infection | MESH:D007239 |